Articles related to BREAST SURGERY

“As an oncologist, when patients lost their hair, my response was, ‘Don’t worry. It will grow back.’ And it will grow back. But it really sucks as you’re waiting.” – Dr. Sue Hwang

Dr. Rita Rao shares her expert perspective on the goals of neoadjuvant therapy, treatment selection, and the evolving landscape of HER2-targeted strategies.

The combination of imlunestrant plus abemaciclib demonstrated significant progression-free survival benefit across all subgroups, including patients with prior CDK4/6 inhibitor use and those with visceral metastases.

In a cohort of 601 women aged ≥65 years with low-risk breast cancer treated without radiotherapy, the 10-year local recurrence rate was 5.5%, with only 0.5% breast cancer-specific mortality.

Breast cancer surgical management requires ongoing patient education to address persistent misconceptions about treatment options and outcomes.

The recent FDA approval of Lumicell’s breast cancer imaging system introduces a novel intraoperative tool that significantly enhances the precision of tumor resections, potentially reducing the need for subsequent corrective surgeries.